Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 158

Results For "ITU"

1812 News Found

RDIF believes that Sputnik vaccines can neutralise Omicron
News | November 30, 2021

RDIF believes that Sputnik vaccines can neutralise Omicron

According to the Russian Direct Investment Fund (RDIF), the Russian Sputnik V and Sputnik Light vaccines have proven to be highly effective against all variants of SARC-Cov-2


Covishield effectiveness during the second wave at 63 per cent
Public Health | November 30, 2021

Covishield effectiveness during the second wave at 63 per cent

Vaccine effectiveness of complete vaccination against the moderate-to-severe disease was at 81 per cent


AMPATH launches its pathology laboratory in Mumbai
Clinical Trials | November 29, 2021

AMPATH launches its pathology laboratory in Mumbai

The company has has 10 existing labs in India


Pharma firms switch to advanced pharma manufacturing
Supply Chain | November 27, 2021

Pharma firms switch to advanced pharma manufacturing

Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies


Aadi Bioscience secures U.S FDA approval of its first product Fyarro
Drug Approval | November 26, 2021

Aadi Bioscience secures U.S FDA approval of its first product Fyarro

Fyarro is the first and only approved therapy for adults for the treatment of malignant PEComa in adults


NFHS-5 shows momentum towards achieving SDG
News | November 25, 2021

NFHS-5 shows momentum towards achieving SDG

The main objective of successive rounds of the NFHS is to provide reliable and comparable data relating to health and family welfare and other emerging issues


Sputnik Light in India by December: RDIF
News | November 25, 2021

Sputnik Light in India by December: RDIF

One-shot Sputnik Light is a highly effective vaccine when used both on standalone basis and applied as a booster


Bharat Biotech updates on the Lancet study on Covaxin efficacy
News | November 25, 2021

Bharat Biotech updates on the Lancet study on Covaxin efficacy

An effectiveness result of 50 per cent achieved during the peak delta variant Covid-19 wave in India, in a highrisk study population of physicians and healthcare workers, in a hospital environment, provides insights into the efficacy and effectiveness of Covaxin


Air pollution reduces life expectancy by eight years in India
News | November 25, 2021

Air pollution reduces life expectancy by eight years in India

India registers 18% of deaths annually due to air pollution while seven million die annually across the world due to air pollution


Gastrointestinal disorders increasing in India
Public Health | November 25, 2021

Gastrointestinal disorders increasing in India

It is estimated that one-third of our country’s population has some form of these disorders